In mouse xenograft models [39], PDL1-blocking Ab or shRNA knockdown synergized with the hormone to diminish tumor cell growth, claiming that the combination of high-dose androgen with PD1/PDL1 inhibitors may ameliorate cancer immunosurveillance. The gene discussed is CD274; the disease is cancer.